| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  HarperCollins Publishers Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 15 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: | 33 | 7 | 15 | 4,188 |
 | The Wall Street Journal Winner of 37 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: | 261 | 159 | 88 | 11,034 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 14 | 2 | 4 | 219 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, Law, Designs, Copyright, Unified Patent Court, and EPO | 8 | 1 | 1 | 598 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 21 | 1 | 19 | 17 |
 |  BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Brussels, BELGIUM -- May 11-13, 2025 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, Polymerisation, … Type: | 38 | 9 | 31 | 2 |
 | Syncona Limited Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of … Type: | 12 | 3 | 2 | 52 |
 |  Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: | 2 | 1 | 2 | 13 |
 | Parkinson's UK We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re … Type: | 23 | 4 | 14 | 644 |
 | BioLabs Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical Type: | 47 | 22 | 41 | 126 |
 | WuXi AppTec The global pharmaceutical and medical device open-access capability and technology platform As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective … Type: | 25 | 2 | 23 | 4,424 |
 | BioCentury Inc. BioCentury gives biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events. When you subscribe to BioCentury, our team of Ph.D.s, analysts and industry experts become an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you the who’s who in the industry. Watch the latest episodes of The BioCentury Show on YouTube www.biocenturyyoutube.com Subscribe to the "BioCentury This Week" … Type: | 42 | 5 | 32 | 73 |
 | Parc Científic de Barcelona [Automatic translation follows] Where Science becomes Business Located in the knowledge campus, the PCB provides you with basic ordinary services and a privileged environment for networking. More than 2,700 highly qualified researchers work at the PCB; join our community! | 37 | 2 | 32 | 110 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 19 | 17 | 0 | 42,027 |
 | Evaluate Ltd Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the … Type: | 28 | 2 | 26 | 187 |
 | Life Science Leader Connect. Collaborate. Contribute. Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth … Type: | 12 | 4 | 7 | 4 |
 | Venture Forward Building a stronger, more diverse, equitable, and inclusive future for venture capital. Venture Forward is a 501(c)(3) supporting organization to NVCA with a mission is to diversify, educate, and empower the VC investor class to advance the industry and maximize impact and returns. The organization provides education, resources, and connections to drive intersectional diversity within the VC community. Venture Forward enables emerging investors to become VC investors by creating opportunities and opening doors that might otherwise have been closed to them. For VC investors and firms, Venture Forward represents a “square one” resource to help them implement meaningful diversity, equity, … Type: | 14 | 3 | 14 | 17 |
 | Youandlaw [Automatic translation follows] Youandlaw is the law firm specializing in the entrepreneurship sector. Youandlaw is the law firm specializing in the entrepreneurship sector. We speak the language of our clients with close, rigorous and flexible advice. Experts in accompanying startups and funds with our advice during their financing rounds. Commercial, Industrial and Intellectual Property, Privacy, Conflict Resolution, and New Technologies | 24 | 1 | 23 | 9 |
 | BIOTECanada Solving for today. Building for tomorrow. BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. Type: | 26 | 3 | 21 | 26 |
 | Citeline Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. Type: | 13 | 10 | 3 | 392 |
 | OBN (UK) Ltd The membership organisation supporting & bringing together UK’s life sciences companies, corporate partners & investors OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our c.500 member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity - Europe's Leading Investment and Biopartnering Conference, find out more at www.biotrinity.com. Networking Events, Partnering (BioTrinity), Advising: Cluster Analysis and Business Development, Group Purchasing Consortium, Advocacy, Conferences, BioTech, and Life Sciences Type: | 33 | 5 | 24 | 30 |
 | Andreessen Horowitz Software is eating the world Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (known as "a16z") is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to late-stage technology companies, across the consumer, enterprise, bio/healthcare, crypto, fintech and games spaces. a16z is defined by respect for the entrepreneur and the entrepreneurial company building process; we know what it’s like to be in the founder’s shoes. The firm is led by general partners, many of whom are former founders/operators, CEOs, or CTOs of successful technology companies, … Type: | 141 | 70 | 32 | 724 |
 | 4BIO Capital London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious … Type: | 9 | 2 | 5 | 17 |
 | McDermott Will & Emery A global law firm helping propel today’s most respected, dynamic and important organizations. McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20+ locations globally, our team works seamlessly across practices, industries and geographies to deliver highly effective—and often unexpected—solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve. Attorney Advertising. Prior results do not guarantee a similar outcome. Type: | 47 | 10 | 21 | 3,142 |
 | Dechert LLP Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients’ rights in extreme situations. Our 1,000+ lawyers across 21 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors. © 2024 Dechert LLP. All rights reserved. This information should not be considered as legal opinions on specific facts or as … Type: | 41 | 11 | 17 | 2,185 |
 | SV Health Investors Investing in tomorrow's healthcare breakthroughs SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology. Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia. Venture Capital, Biotechnology, Medical Devices, Healthcare services, Private Equity, and Dementia Type: | 25 | 5 | 21 | 100 |
 | RELEVATION The Global digital fundraising Summit for PropTech startups Relevation.org is the global digital investment summit in UrbanTech; a 2 days event of match-making between investors (BA, family offices, VC, CVC...) and startups across all the stages of maturity in fund raising process Type: | 28 | 7 | 26 | 2 |
 | ICREA - Institució Catalana de Recerca i Estudis Avançats The need to know ICREA, Catalan Institution for Research and Advanced Studies, is a foundation supported by the Catalan Government and guided by a Board of Trustees. ICREA was created in response to the need to seek new hiring formulas that would make it possible to compete with other research systems on a similar footing by focusing on hiring only the most talented and extraordinary scientists and academics. ICREA is an institution without walls. It works hand in hand with Catalan universities and research centres to integrate ICREA research professors in the Catalan research system. ICREA offers permanent, tenured positions … Type: | 34 | 4 | 25 | 60 |
 | Headline We help founders win, bigger Headline is a Venture Capital firm actively on the ground in 7 cities around the world. We invest across geographies, leading rounds at every stage. Once we commit to a team, we go to the ends of the earth to make their success global. Our Early Stage Funds are based in the US, Europe, Asia, and Brazil, and invest locally. Our San Francisco-based Growth Fund invests globally from Series B and beyond, working in collaboration with our Early Stage Teams. The sizes and locations of these funds make it possible for us to see local … Type: | 26 | 17 | 12 | 207 |
 | Milano Finanza [Automatic translation follows] The best of economic and financial information, always at your disposal. MF-Milano Finanza is the national financial and economic newspaper, with the primacy of information on the stock market, economy, investments and markets. A direct line to Piazza Affari and the main world stock exchanges. With dedicated sections: Online trading, Technical Analysis, ETF, Covered Warrant, Private Equity, Shipping & Logistics and on Saturday with Milano Finanza important insights into the world of managed savings, securities and real estate investments. The correctness, truthfulness and authoritativeness of the newspaper are recognized by the target and by professionals both at … Type: | 32 | 17 | 8 | 334 |
 | Sixth Street Global investors developing themes and offering solutions to companies across all stages of growth Sixth Street is a global investment firm with over $75 billion in assets under management and committed capital. We use our long-term flexible capital, data-enabled capabilities, and One Team culture to develop themes and offer solutions to companies across all stages of growth. Sixth Street is dedicated to cross-platform collaboration at scale. We have more than 600 team members including over 250 investment professionals operating across our global locations. We invest through our diversified, collaborative investment platforms: TAO, Growth, Direct Lending, Strategic Capital, Fundamental Strategies, Infrastructure, … Type: | 5 | 3 | 2 | 732 |
 | BeBeez Italia [Automatic translation follows] The first publisher specialized in news and services on private investments in venture capital and debt EdiBeez is the publisher of BeBeez.it and CrowdfundingBuzz.it BeBeez is an online newspaper registered with the Court of Milan (Authorization no. 102 of April 3, 2013), born in the spring of 2013 from an idea by Stefania Peveraro (head of service of MF Milano Finanza) and Anna Gervasoni (general director of the Italian Association of Private Equity and Venture Capital, AIFI). Crowdfunding Buzz is a magazine dedicated to collecting news and information related to all forms of crowdfunding. Born in December … | 42 | 0 | 41 | 10 |
 | Osage University Partners (OUP) Venture capital for university innovation. All sectors, all stages, all in. Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research. OUP firmly believes that universities provide an unparalleled innovation engine and we have partnered with over 100 of the most entrepreneurial universities and research centers to invest in their startups. Profits are shared with affiliated institutions to further promote the university entrepreneurial ecosystem. Physical Sciences, Life Science, entrepreneurship, University Innovation, VC, Venture Capital, investing, startups, university startup, technology transfer, biotech, and science Type: | 28 | 1 | 24 | 21 |
 | LCA Studio Legale Your business partner LCA is an independent, full-service law firm, specialised in providing legal assistance to companies worldwide. Our offices are in Italy (Milan, Rome, Genoa, Treviso), Belgium (Brussels), and the United Arab Emirates (Dubai), where we operate in an International Partnership with IAA Middle East Legal Consultants LLP. LCA employs over 250 professionals specialised in all main areas of commercial, corporate, banking, finance, restructuring, tax, criminal, real estate, and labour law, and in all aspects of business law - including intellectual property, new technologies, transportation and insurance issues, art and food regulations - and in the protection of family … | 9 | 2 | 6 | 383 |
 | Jefferies Jefferies, the global investment banking firm serving clients for more than 60 years. Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com. Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services Type: | 26 | 8 | 8 | 7,802 |
 | BioIndustry Association (BIA) The award-winning trade association for the innovative life sciences and biotech companies in the UK The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. BIA is a trade association with 490+ member companies including: - Start-ups, biotechnology and innovative life science companies - Pharmaceutical and technological companies - Universities, research centres, tech transfer offices, incubators and accelerators - A wide range of life science service providers: investors, lawyers, IP consultants, IR agencies BIA is the key thought leader … Type: | 51 | 7 | 42 | 67 |
 | American Society of Gene & Cell Therapy ASGCT is the primary membership organization for professionals working in gene and cell therapy. The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for … Type: | 15 | 1 | 15 | 66 |
 | The Oxford Science Park The Oxford Science Park is one of the most influential science, technology and business environments in the UK for more than 2,500 people in over 70 companies, ranging from start-ups to SMEs and multi-national organisations. It was created in 1991 and is owned and managed by Magdalen College Oxford, one of Oxford’s oldest and most famous colleges with a tradition of academic excellence and entrepreneurship. The Park continues to uphold the College’s heritage. People who work here enjoy 75 acres of beautifully landscaped grounds and an atmosphere of discovery, innovation and entrepreneurship. Offices, Laboratories, and Conference and Meeting rooms for … Type: | 36 | 3 | 34 | 14 |
 | Octopus Ventures For the people and ideas that will change the world. For the people and ideas that will change the world, because we believe you can build a better tomorrow by investing in it. We can back you at every stage of your journey, from ideas on a page through to IPO. Each year we deploy more than £200 million across five areas where we see maximum potential for impact: health, fintech, deep tech, consumer and B2B software. With many years of experience and expertise investing in each of these areas, our team can help our portfolio companies scale at speed. … Type: | 84 | 35 | 31 | 123 |
 | Federal Ministry for Economic Affairs and Climate Action The major trends of the 21st century, notably globalisation, digitisation, demographic change, recent developments within the EU, and climate change all represent major challenges for German business to tackle. If we are to successfully address these issues, we need to develop our social market economy into a social-ecological market economy. This is the over-arching task for the Federal Ministry for Economic Affairs and Climate Action. Wirtschaft, Digitalisierung, Handelspolitik, Mittelstandspolitik, Energiewende, Europa, Wirtschaftliche Entwicklung, Industriepolitik, Luft- und Raumfahrt, Erneuerbare Energien, Außenwirtschaftsförderung, Existenzgründung, Tourismuspolitik, Energieeffizienz, Maritime Wirtschaft, Netzausbau, and Industrie 4.0 Type: | 99 | 43 | 27 | 1,001 |
 | International Union of Crystallography Advancing crystallography and structural science through primary research publication and extensive outreach activities The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences. Publishing, Crystallography, Open Access, Science, journals, online communities, and databases Type: | 19 | 2 | 14 | 129 |
 | Innogest Capital Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside … Tags: H2020 Type: | 11 | 1 | 3 | 16 |
 | Atlas Venture We build breakthrough biotech companies with remarkable life science entrepreneurs. Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. Biotech and Venture Capital Type: | 25 | 5 | 14 | 137 |
 | Wellington Partners Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years. We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million. Providing funding is only one part of our business. After funding, the entrepreneurs … Type: | 26 | 11 | 4 | 36 |
 | AltAssets Private Equity News Daily news and insights for private equity and venture capital. Free newsletter here! https://www.altassets.net/register AltAssets connects LPs and GPs worldwide. We have been serving the global private equity industry for over a decade and have become established as a trusted source of independent news and views on the industry by thousands of professionals worldwide. Our online news service is the world's most widely used source of information with 450,000 individuals accessing the site to gain insights on investments in private equity, venture capital, real estate and infrastructure funds. We also host invitation-only LP-GP Forums to connect active LPs with the … Type: | 24 | 4 | 20 | 12 |
 | Dieter von Holtzbrinck Ventures DvH Ventures | Investing early in Europe's most passionate founders. Dieter von Holtzbrinck Ventures (DvH Ventures) is one of Europe's leading early stage investors. As an entrepreneurial venture capitalist, DvH Ventures invests in emerging technology companies and builds successful investment clusters in areas such as Digital Health, Education, DeepTech or Climate Tech/ESG. Founded in 2014, partners Duc Quyen Tran, Peter Richarz and Fabian von Trotha manage several venture capital funds from their Cologne office. In addition to financial investments, DvH Ventures supports its portfolio companies with management expertise, in-depth industry knowledge and an international investor network. An exclusive media-for-equity programme … Type: | 30 | 6 | 19 | 10 |
 | Invest Europe The Voice of Private Capital Invest Europe - The Voice of Private Capital Invest Europe is the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors. Our members take a long-term approach to investing in privately held companies, from start-ups to established firms. They inject not only capital but dynamism, innovation and expertise. This commitment helps deliver strong and sustainable growth, resulting in healthy returns for Europe’s leading pension funds and insurers, to the benefit of the millions of European citizens who depend on them. Invest Europe aims to make a constructive contribution to … Type: | 71 | 20 | 52 | 93 |
 | Moorfields Eye Hospital, London Moorfields is one of the world’s leading eye hospitals, providing expertise in clinical care, research and teaching and education. Our main focus is the treatment and care of NHS patients with a wide range of eye problems, from common complaints to rare conditions, which require treatments not available anywhere else in the UK. We have over 30 locations in and around London, which enables us to provide expert treatment closer to patients’ homes. We are also a postgraduate teaching centre and a national centre for ophthalmic research involving, with the UCL Institute of Ophthalmology, the largest ophthalmic research programme in … Type: | 11 | 6 | 2 | 1,791 |
 | Latham & Watkins Latham & Watkins is a global law firm with more than 3,500 lawyers in its offices located in Asia, Europe, the Middle East and the United States. The firm has internationally recognized practices in a wide spectrum of transactional, litigation, corporate and regulatory areas. Our success is grounded in our devotion to the collaborative process, which reaches across global offices and practices and draws upon our deep subject matter expertise, an abiding commitment to teamwork and a powerful tradition of creative lawyering. Follow us on Twitter @lathamwatkins Join us on Facebook www.facebook.com/lathamwatkins Subscribe to us on YouTube http://youtube.com/lathamwatkinsglobal Content may … Type: | 88 | 13 | 41 | 7,633 |
 | Enrupt Building companies of the future Transition is not enough. We require a radical change, we require a transformation to achieve tangible changes in our business and society centered on net zero objective by 2050. We are 25 years from 2050 and any asset or infrastructure invested today will still be in operation by 2050. We can’t dream of a better world. We need to create it by our actions today. We need to disrupt energy in us, our organisations and around us. energy, innovation, startups, decarbonisation, decentralisation, and digitalisation Type: | 7 | 0 | 7 | 1 |
 | Unquote Unquote is dedicated to providing insightful news, analysis and research surrounding the European private equity industry. While many other information sources rely purely on press releases they receive, unquote.com fully researches all the deals, funds and exits taking place in the market - fully verifying the information directly with the private equity deal-doers, fund managers, institutional investors and advisory communities. We have been researching the markets for over 20 years and that’s how we've become the leading European private equity specialists. Follow us for intelligence and analysis based on verified information and hard facts, not rumour and speculation. Type: | 37 | 7 | 31 | 2 |
 | Quoroom Raise capital and manage investor relations, reporting, legals and compliance seamlessly in one place. Quoroom is a capital raising and investor relations software for founders, syndicates and funds. Investment managers and founders use Quoroom to manage investor relations, investor onboarding, legal singing, compliance and exit distributions while saving thousands in software and legal fees annually. For Founders: Investor CRM, Data Room, Legals, Cap Table, Investor Update, Employee Options, Liquidity Events. For Syndicates / Funds: Investor CRM, Data room, LPs onboarding, KYC/AML, Regulatory Framework, SPVs, Legal document and E-Signing, LPs registers, Capital Statements, Secondary transfers, Distributions (Private equity and debt) Investments, … Type: | 20 | 4 | 17 | 10 |
 | OrbiMed OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets. Biotechnology, Healthcare, Financial Services, Fund Management, and Investment Management Type: | 18 | 4 | 7 | 148 |
 | Longwood Fund Longwood creates and invests in science-based companies that develop novel solutions for important medical problems Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Healthcare and Biotech and entrepreneurialism Type: | 25 | 2 | 20 | 19 |
 | Gilde Healthcare Specialized healthcare investor in both Healthcare Venture & Growth as well as Healthcare Private Equity, managing €2.5B Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are … Type: | 11 | 4 | 2 | 63 |
 | Amadeus Capital Partners We invest in people who create transformational technologies and sustainable businesses. Amadeus Capital Partners is a global technology investor. Since 1997, the firm has raised over $1bn for investment and used it to back more than 180 companies. With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. Pioneering businesses we’ve backed include cyber security vendor ForeScout (NASDAQ:FSCT); Graphcore, innovators in intelligent microprocessors; IVF genetic testing company, Igenomix; the first single-chip Bluetooth solution, CSR (acquired by Qualcomm); IndiaMART, the B2B online marketplace (NSE: INDIAMART) and speech recognition company … Type: | 58 | 13 | 28 | 47 |
 | Funding London We bridge the funding gap for SMEs in London and enable real opportunities for sustainable growth. Funding London channels funding from Europe and the UK to sustainable and ambitious SME’s of London via designated fund managers. Returns from our investments are ploughed back in the funding ecosystem of London, making investments available to the next generation. The Greater London Investment Fund (GLIF), a £100 million Fund of Funds, provides equity and loan finance to London SMEs, through investment in three sub-funds. MMC Ventures manage the equity fund and FSE Fund Managers manage the two loan funds. The London Co-Investment Fund … Type: | 27 | 1 | 26 | 9 |
 | Principles for Responsible Investment The UN-supported Principles for Responsible Investment, the world’s leading proponent of responsible investment. The Principles for Responsible Investment (PRI) is an investor initiative in partnership with UNEP FI and the UN Global Compact. Founded in 2006 and supported by the United Nations, the PRI has become the leading network for investors demonstrating their commitment to responsible ownership and long-term, sustainable returns. Pension funds, insurance companies, sovereign/development funds, investment managers and service providers make up the PRI network. Our goal is to grow investor interest in environmental, social and corporate governance issues (ESG), share best practice and support signatory needs in … Type: | 71 | 27 | 33 | 343 |
 | All Raise Move Money. Shift Power. Change Culture. All Raise is on a mission to accelerate the success of female and non-binary founders and funders to build a more prosperous, equitable future. Born out of a grassroots movement in 2017, our programs arm women with access, guidance, and support to advance their professional growth. When the architects of tomorrow better reflect the world, our world is better served. Type: | 46 | 10 | 32 | 121 |
 | T. Rowe Price T. Rowe Price is a premiere global asset management organization, actively investing in opportunities to help people thrive in an evolving world. Headquartered in Baltimore, Maryland, we provide a broad range of investment solutions across equity, fixed income, and multi-asset capabilities for clients around the world—from individuals to advisors to institutions to retirement plan sponsors. Our active, independent investing approach has guided how we do business for more than 85 years. Our professionals have diverse perspectives, but are united behind a commitment to rigorous research. They collaborate to identify market risks and opportunities that can give clients sharper insights and … Type: | 34 | 4 | 1 | 8,987 |
 | The Carlyle Group Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment Solutions. With $435 billion of assets under management as of June 30, 2024, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 2,200 people in 29 offices across four continents. Notices & Disclaimers: https://www.carlyle.com/notices-and-disclaimers AlpInvest Private Equity Investment Management, LLC (“APEIM”) is the investment advisor to Carlyle AlpInvest Private Equity Markets (CAPM) … Type: | 66 | 25 | 12 | 2,441 |
 | Linklaters Linklaters is a leading global law firm, supporting and investing in the future of our clients wherever they do business. We combine legal expertise with a collaborative and innovative approach to help clients navigate constantly evolving markets and regulatory environments, pursuing opportunities and managing risk worldwide. http://www.linklaters.com Attorney Advertising: Prior results do not guarantee a similar outcome Type: | 105 | 25 | 50 | 14 |
 | Evonik Leading in specialty chemicals and beyond to make the world a better place. Evonik is one of the world’s leading specialty chemicals companies. While we don’t produce electric cars, aircraft, medications or 3D printers, Evonik is part and parcel of these and many other end products. That’s because we contribute the small things that make a big difference. We make electric car batteries perform better, aircraft greener, medications more effective and 3D printers more efficient. In short: We think beyond the bounds of chemistry to make the world a better place. Today and tomorrow. We are an international group with … Type: | 68 | 23 | 32 | 13,849 |
 | AlbionVC Backing visionary founders with long-term capital & scale-up expertise. Partners to B2B software & healthcare companies. AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage software, healthcare and deeptech companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority. Type: | 68 | 15 | 48 | 31 |
 | MedTech Innovator The medtech industry's global competition & accelerator, and the largest accelerator of medical technology in the world MedTech Innovator is the industry’s nonprofit global competition and the largest accelerator in the world for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. Type: | 18 | 8 | 9 | 96 |
 | F-Prime Capital We create and invest in healthcare and technology companies that impact lives all over the world. Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds … Type: | 33 | 8 | 15 | 96 |
 | HLTH USA Boldly stepping into health's future 🦄 Be bold and join us at HLTH USA 2024 October 20-24. HLTH is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a better health ecosystem. Join us in transforming the next decade of health, together. Type: | 46 | 10 | 32 | 73 |
 | The Francis Crick Institute We are a biomedical discovery institute breaking down barriers between disciplines. The Crick is a distinctive biomedical research institute. We’re committed to advancing, promoting, and sharing understanding of human health and disease. We do that by attracting talented and ambitious people from all disciplines and backgrounds and giving them the support and freedom they need to succeed. Inside the Crick, you’ll discover scientists working to stretch the very limits of what we know about how life works. Their research holds the key to answering fundamental questions about human health and disease. Our bold and innovative research projects bring together scientists … Type: | 42 | 12 | 19 | 1,706 |
 | EuropaBio - the European Association for Bioindustries Innovative biotechnology, benefiting people and planet. EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. Type: | 39 | 10 | 36 | 32 |
 | Nature Portfolio Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, … Type: | 61 | 33 | 13 | 764 |
 | California Life Sciences (CLS) California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization. California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this … Type: | 37 | 5 | 35 | 11 |
 | LSX LSX is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life., LSX is the network for life science executive leaders. Take a … Type: | 57 | 7 | 45 | 5 |
 | Lnk.Bio | 321 | 137 | 322 | 21 |
 | EQT Group EQT is a purpose-driven global investment organization EQT is a purpose-driven global investment organization with close to three decades of consistent investment performance across multiple geographies, sectors, and strategies. Type: | 39 | 18 | 14 | 1,291 |
 | Stifel Type: | 22 | 7 | 10 | 6,009 |
 | Media Affairs MediaAffairs entwickelt Wissen über Medienmärkte. Damit unterscheidet sich das Unternehmen wesentlich von konventionellen Anbietern aus dem Bereich der Medien(resonanz)analyse, die – auf gänzlich andere Art und Weise – Daten über Unternehmen, Personen, Themen usw. sammeln und als Informationen über das mediale Geschehen an ihre Kunden übermitteln. Auch MediaAffairs analysiert Medien, erarbeitet Statistiken über Präsenz, Themenführerschaft u.v.m. Darüber hinaus aber kennen wir die Medienmärkte, die wir im Auftrag unserer Kunden beschreiben. Daraus ergibt sich eine einzigartige Expertise unserer Mitarbeiter, mit der diese jede Information über das mediale Geschehen anreichern. Dies ist eine der wesentlichen Voraussetzungen, die uns für den professionellen Dialog … Type: | 91 | 52 | 1 | 16,540 |
Media